Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses

Antipsychotic prescribing is dominated by olanzapine, quetiapine, risperidone and aripiprazole. We identified potential disparities in both the receipt and prescribed doses of antipsychotics across subgroups. To inform efforts to optimise prescribing and ensure equity of care, further research is needed to understand why certain groups are prescribed higher doses and are more likely to be treated with long-acting injectable antipsychotics compared with others.

Authors

Institutions

Publication Details

Journal
The British Journal of Psychiatry
Published
2024-12-18
DOI
https://doi.org/10.1192/bjp.2024.186
Citations
5
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.93

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses

Sarah Hardoon, David Osborn, Kenneth K. C. Man, Alvin Richards‐Belle et al.
5 citations
The British Journal of Psychiatry
Schizophrenia research and treatment
1.93
article

Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses

Sarah Hardoon, David Osborn, Kenneth K. C. Man, Alvin Richards‐Belle, Naomi Launders, Elvira Bramon, Joseph Hayes
article en
5 citations

Abstract

Antipsychotic prescribing is dominated by olanzapine, quetiapine, risperidone and aripiprazole. We identified potential disparities in both the receipt and prescribed doses of antipsychotics across subgroups. To inform efforts to optimise prescribing and ensure equity of care, further research is needed to understand why certain groups are prescribed higher doses and are more likely to be treated with long-acting injectable antipsychotics compared with others.

The British Journal of PsychiatryVol. 226(5)
University College London Hospitals NHS Foundation Trust (GB), Chinese University of Hong Kong (HK), University College London (GB), University of Hong Kong (HK), Camden and Islington NHS Foundation Trust (GB)
Mental Health Research UK, Wellcome Trust, UK Research and Innovation, National Institute for Health and Care Research, Department of Health and Social Care, British Medical Association, University College London, European Commission, Innovation and Technology Commission, University College London Hospitals NHS Foundation Trust, Medical Research Council, School of Pharmacy, University College London, Li Ka Shing Faculty of Medicine, University of Hong Kong
Openalex Percentile: Top 12%
Schizophrenia research and treatment
1.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.